Examination of medication adherence and physical / mental function improvement effect of combination tablets (SGLT2-I and DPP4-I)
Latest Information Update: 22 Dec 2021
At a glance
- Drugs Empagliflozin (Primary) ; Empagliflozin/linagliptin (Primary) ; Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Sep 2021 New trial record